What is the maximum number of laser trabeculoplasty treatments (selective laser trabeculoplasty and argon laser trabeculoplasty) that can be safely administered?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Maximum Number of Laser Trabeculoplasty Treatments

For Selective Laser Trabeculoplasty (SLT), repeat treatments can be performed multiple times with similar efficacy to initial treatment, while for Argon Laser Trabeculoplasty (ALT), repeat treatment after full 360-degree initial treatment has poor long-term success and should generally be limited to one repeat at most.

Argon Laser Trabeculoplasty (ALT)

The evidence clearly demonstrates significant limitations for repeat ALT treatments 1:

  • After initial 360-degree ALT treatment, repeat ALT has a low long-term success rate with failure occurring in nearly 90% of eyes by 2 years 1
  • Repeat ALT should only be considered in eyes that have not had IOP reduction for at least a year following the first laser surgery 1
  • Compared with initial laser trabeculoplasty, there is an increased risk of complications such as IOP spikes after repeat ALT 1

Practical ALT Algorithm:

  • First treatment: Can be performed to 180 or 360 degrees
  • Second treatment: Only if the first treatment maintained IOP reduction for at least 1 year, but expect lower success rate (90% failure by 2 years)
  • Third treatment: Not recommended based on guideline evidence

Selective Laser Trabeculoplasty (SLT)

The evidence for SLT is more favorable regarding repeatability 1:

  • Similar IOP reduction and success rates have been observed with repeat SLT compared with initial SLT in retrospective studies 1
  • SLT produces less thermal damage to the trabecular meshwork compared with ALT, theoretically allowing for more repeat treatments 1
  • Level I evidence from 2024 confirms SLT is effective long-term and can be repeated 2

Research Evidence Supporting Multiple SLT Treatments:

A 2014 study found that patients with previous failed ALT had significantly better IOP reduction with SLT retreatment (6.8 mmHg) versus repeat ALT (3.6 mmHg) 3. Another study demonstrated that SLT retreatment was more effective than ALT retreatment, with IOP lowering of 6.24 mmHg versus 4.65 mmHg respectively 3.

The largest safety study analyzing 6,081 SLT treatments (4,601 eyes) found only one permanent vision deterioration, demonstrating excellent safety even with multiple treatments 4.

Practical SLT Algorithm:

  • First treatment: 180 or 360 degrees
  • Second treatment: Can be performed with similar efficacy to first treatment
  • Third and subsequent treatments: While no specific maximum is defined in guidelines, retrospective data supports repeatability with maintained efficacy 1, 5

Key Clinical Considerations

Important caveats:

  • Eyes with heavily pigmented trabecular meshwork are more prone to IOP spikes after both SLT and ALT (4.5% to 27% incidence) 1
  • One study suggests maximal SLT response in patients with significant trabecular pigmentation may not occur until after at least two sessions 5
  • High myopia (≤-5.00 D) carries a rare risk of permanent corneal complications (1/648 treatments), though overall complication rates remain very low 4

Post-treatment monitoring requirements 1:

  • IOP check within 30 minutes to 2 hours after surgery
  • Follow-up examination within 6 weeks of surgery
  • Treating 180 degrees reduces the incidence and magnitude of postoperative IOP elevation compared with 360-degree treatment

Bottom Line

While ALT should generally be limited to one initial treatment and possibly one repeat (with poor expected outcomes), SLT can be repeated multiple times with maintained efficacy and safety, making it the preferred laser trabeculoplasty modality when repeat treatments are anticipated 1, 3, 2.

References

Related Questions

Should an asymptomatic urine culture with 10,000–49,000 CFU/mL Escherichia coli be treated?
What is the minimum recommended duration of antimicrobial therapy for a deep puncture wound?
A 10‑day postpartum woman presents with dysuria and a urine culture growing mixed microbiota >100,000 CFU/mL; how should this be managed?
What is the appropriate 10‑day antibiotic regimen for a patient undergoing ENT follow‑up after image‑guided fine‑needle aspiration/biopsy, assuming no documented β‑lactam allergy?
In a 56-year-old male with persistent testicular pain and a normal scrotal ultrasound, would a spermatic cord block be beneficial, and what outcomes and follow‑up treatment should be expected if the block improves his pain?
Is pentadecanoic acid (C15:0) safe for consumption as a dietary supplement?
When should a serum vancomycin trough level be drawn in a hemodialysis patient who received a loading dose at 1 am on Friday, with dialysis scheduled on Tuesday, Thursday, and Saturday?
Should a patient with postural orthostatic tachycardia syndrome (POTS) avoid tetrahydrocannabinol (THC) and how can cannabidiol (CBD) be safely initiated and dosed?
What are the differential diagnoses for a 58‑year‑old man with subacute balance impairment, low‑grade fever, descending weakness, headache, neck stiffness, speech and memory changes over two weeks, normal CT/MRI, negative initial lumbar puncture, marked leukocytosis and elevated C‑reactive protein, iron‑deficiency anemia, and partial improvement with intravenous antibiotics that recurs after discontinuation?
What is the recommended dosing and monitoring of insulin aspart in a patient with acute renal failure?
Are there any drug interactions between erythromycin ophthalmic ointment and Augmentin (amoxicillin‑clavulanate) when used together?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.